カテゴリ： 世界, 医療/バイオ, QYResearch

薬剤溶出性ステントの世界市場2023年：頸動脈、腸骨動脈、股間節動脈、腎動脈、頸動脈

■ 英語タイトル：Global Drug Eluting Peripheral Stents Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7825）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7825
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[薬剤溶出性ステントの世界市場2023年：頸動脈、腸骨動脈、股間節動脈、腎動脈、頸動脈]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は薬剤溶出性ステントのグローバル市場について調査・分析し、世界の薬剤溶出性ステント市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（頸動脈、腸骨動脈、股間節動脈、腎動脈、頸動脈）、用途別セグメント分析（病院、専門クリニック、外来手術センター、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Boston Scientific Corporation、W. L. Gore & Associates、Abbott Laboratories、iVascular SLU.、Meril Life Sciences Pvt. Ltd.、Stentys SA, Cook Medical Inc.などが含まれています。薬剤溶出性ステントのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、薬剤溶出性ステント市場規模を算出する際に考慮しました。

・薬剤溶出性ステント市場の概要
- 製品の定義
- 薬剤溶出性ステントの種類別セグメント
- 世界の薬剤溶出性ステント市場規模：タイプ別分析（頸動脈、腸骨動脈、股間節動脈、腎動脈、頸動脈）
- 薬剤溶出性ステントの用途別セグメント
- 世界の薬剤溶出性ステント市場規模：用途別分析（病院、専門クリニック、外来手術センター、その他）
- 世界の薬剤溶出性ステント市場規模予測（2018年-2029年）
- 薬剤溶出性ステントの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 薬剤溶出性ステント市場の競争状況およびトレンド

・薬剤溶出性ステントの地域別市場規模
- 北米の薬剤溶出性ステント市場規模（2018年-2029年）
- 米国の薬剤溶出性ステント市場規模（2018年-2029年）
- ヨーロッパの薬剤溶出性ステント市場規模（2018年-2029年）
- アジア太平洋の薬剤溶出性ステント市場規模（2018年-2029年）
- 中国の薬剤溶出性ステント市場規模（2018年-2029年）
- 日本の薬剤溶出性ステント市場規模（2018年-2029年）
- 韓国の薬剤溶出性ステント市場規模（2018年-2029年）
- インドの薬剤溶出性ステント市場規模（2018年-2029年）
- オーストラリアの薬剤溶出性ステント市場規模（2018年-2029年）
- 中南米の薬剤溶出性ステント市場規模（2018年-2029年）
- 中東・アフリカの薬剤溶出性ステント市場規模（2018年-2029年）

・種類別セグメント：頸動脈、腸骨動脈、股間節動脈、腎動脈、頸動脈
- 世界の薬剤溶出性ステントのタイプ別販売量（2018年-2023年）
- 世界の薬剤溶出性ステントのタイプ別売上（2018年-2023年）
- 世界の薬剤溶出性ステントのタイプ別価格

・用途別セグメント：病院、専門クリニック、外来手術センター、その他
- 世界の薬剤溶出性ステントの用途別販売量（2018年-2023年）
- 世界の薬剤溶出性ステントの用途別売上（2018年-2023年）
- 世界の薬剤溶出性ステントの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Boston Scientific Corporation、W. L. Gore & Associates、Abbott Laboratories、iVascular SLU.、Meril Life Sciences Pvt. Ltd.、Stentys SA, Cook Medical Inc.

・産業チェーンと販売チャネルの分析
- 薬剤溶出性ステント産業チェーン分析
- 薬剤溶出性ステントの主要原材料
- 薬剤溶出性ステントの販売チャネル
- 薬剤溶出性ステントのディストリビューター
- 薬剤溶出性ステントの主要顧客

・薬剤溶出性ステント市場ダイナミクス
- 薬剤溶出性ステントの業界動向
- 薬剤溶出性ステント市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Drug Eluting Peripheral Stents market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Drug Eluting Peripheral Stents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Drug Eluting Peripheral Stents is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Drug Eluting Peripheral Stents include Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd. and Stentys SA, Cook Medical Inc., etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Peripheral Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Peripheral Stents.
The Drug Eluting Peripheral Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Eluting Peripheral Stents market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Peripheral Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Boston Scientific Corporation
W. L. Gore & Associates
Abbott Laboratories
iVascular SLU.
Meril Life Sciences Pvt. Ltd.
Stentys SA, Cook Medical Inc.
Segment by Type
Carotid Artery
Iliac Artery
Infrapop Artery
Renal Artery
Carotid Artery
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers/Outpatients
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Peripheral Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Peripheral Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Drug Eluting Peripheral Stents Market Overview
1.1 Product Overview and Scope of Drug Eluting Peripheral Stents
1.2 Drug Eluting Peripheral Stents Segment by Type
1.2.1 Global Drug Eluting Peripheral Stents Market Value Comparison by Type (2023-2029)
1.2.2 Carotid Artery
1.2.3 Iliac Artery
1.2.4 Infrapop Artery
1.2.5 Renal Artery
1.2.6 Carotid Artery
1.3 Drug Eluting Peripheral Stents Segment by Application
1.3.1 Global Drug Eluting Peripheral Stents Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers/Outpatients
1.4 Global Drug Eluting Peripheral Stents Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Peripheral Stents Revenue 2018-2029
1.4.2 Global Drug Eluting Peripheral Stents Sales 2018-2029
1.4.3 Global Drug Eluting Peripheral Stents Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Drug Eluting Peripheral Stents Market Competition by Manufacturers
2.1 Global Drug Eluting Peripheral Stents Sales Market Share by Manufacturers (2018-2023)
2.2 Global Drug Eluting Peripheral Stents Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Drug Eluting Peripheral Stents Average Price by Manufacturers (2018-2023)
2.4 Global Drug Eluting Peripheral Stents Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Drug Eluting Peripheral Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Peripheral Stents, Product Type & Application
2.7 Drug Eluting Peripheral Stents Market Competitive Situation and Trends
2.7.1 Drug Eluting Peripheral Stents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Peripheral Stents Players Market Share by Revenue
2.7.3 Global Drug Eluting Peripheral Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Peripheral Stents Retrospective Market Scenario by Region
3.1 Global Drug Eluting Peripheral Stents Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Drug Eluting Peripheral Stents Global Drug Eluting Peripheral Stents Sales by Region: 2018-2029
3.2.1 Global Drug Eluting Peripheral Stents Sales by Region: 2018-2023
3.2.2 Global Drug Eluting Peripheral Stents Sales by Region: 2024-2029
3.3 Global Drug Eluting Peripheral Stents Global Drug Eluting Peripheral Stents Revenue by Region: 2018-2029
3.3.1 Global Drug Eluting Peripheral Stents Revenue by Region: 2018-2023
3.3.2 Global Drug Eluting Peripheral Stents Revenue by Region: 2024-2029
3.4 North America Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.4.1 North America Drug Eluting Peripheral Stents Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Drug Eluting Peripheral Stents Sales by Country (2018-2029)
3.4.3 North America Drug Eluting Peripheral Stents Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Peripheral Stents Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Drug Eluting Peripheral Stents Sales by Country (2018-2029)
3.5.3 Europe Drug Eluting Peripheral Stents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Peripheral Stents Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Drug Eluting Peripheral Stents Sales by Country (2018-2029)
3.6.3 Asia Pacific Drug Eluting Peripheral Stents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Peripheral Stents Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Drug Eluting Peripheral Stents Sales by Country (2018-2029)
3.7.3 Latin America Drug Eluting Peripheral Stents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Peripheral Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Peripheral Stents Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Drug Eluting Peripheral Stents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Drug Eluting Peripheral Stents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Peripheral Stents Sales by Type (2018-2029)
4.1.1 Global Drug Eluting Peripheral Stents Sales by Type (2018-2023)
4.1.2 Global Drug Eluting Peripheral Stents Sales by Type (2024-2029)
4.1.3 Global Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2029)
4.2 Global Drug Eluting Peripheral Stents Revenue by Type (2018-2029)
4.2.1 Global Drug Eluting Peripheral Stents Revenue by Type (2018-2023)
4.2.2 Global Drug Eluting Peripheral Stents Revenue by Type (2024-2029)
4.2.3 Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2018-2029)
4.3 Global Drug Eluting Peripheral Stents Price by Type (2018-2029)
5 Segment by Application
5.1 Global Drug Eluting Peripheral Stents Sales by Application (2018-2029)
5.1.1 Global Drug Eluting Peripheral Stents Sales by Application (2018-2023)
5.1.2 Global Drug Eluting Peripheral Stents Sales by Application (2024-2029)
5.1.3 Global Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2029)
5.2 Global Drug Eluting Peripheral Stents Revenue by Application (2018-2029)
5.2.1 Global Drug Eluting Peripheral Stents Revenue by Application (2018-2023)
5.2.2 Global Drug Eluting Peripheral Stents Revenue by Application (2024-2029)
5.2.3 Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2018-2029)
5.3 Global Drug Eluting Peripheral Stents Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Corporation Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Boston Scientific Corporation Drug Eluting Peripheral Stents Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 W. L. Gore & Associates
6.2.1 W. L. Gore & Associates Corporation Information
6.2.2 W. L. Gore & Associates Description and Business Overview
6.2.3 W. L. Gore & Associates Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2018-2023)
6.2.4 W. L. Gore & Associates Drug Eluting Peripheral Stents Product Portfolio
6.2.5 W. L. Gore & Associates Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Laboratories Drug Eluting Peripheral Stents Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 iVascular SLU.
6.4.1 iVascular SLU. Corporation Information
6.4.2 iVascular SLU. Description and Business Overview
6.4.3 iVascular SLU. Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 iVascular SLU. Drug Eluting Peripheral Stents Product Portfolio
6.4.5 iVascular SLU. Recent Developments/Updates
6.5 Meril Life Sciences Pvt. Ltd.
6.5.1 Meril Life Sciences Pvt. Ltd. Corporation Information
6.5.2 Meril Life Sciences Pvt. Ltd. Description and Business Overview
6.5.3 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product Portfolio
6.5.5 Meril Life Sciences Pvt. Ltd. Recent Developments/Updates
6.6 Stentys SA, Cook Medical Inc.
6.6.1 Stentys SA, Cook Medical Inc. Corporation Information
6.6.2 Stentys SA, Cook Medical Inc. Description and Business Overview
6.6.3 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product Portfolio
6.6.5 Stentys SA, Cook Medical Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Peripheral Stents Industry Chain Analysis
7.2 Drug Eluting Peripheral Stents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Peripheral Stents Production Mode & Process
7.4 Drug Eluting Peripheral Stents Sales and Marketing
7.4.1 Drug Eluting Peripheral Stents Sales Channels
7.4.2 Drug Eluting Peripheral Stents Distributors
7.5 Drug Eluting Peripheral Stents Customers
8 Drug Eluting Peripheral Stents Market Dynamics
8.1 Drug Eluting Peripheral Stents Industry Trends
8.2 Drug Eluting Peripheral Stents Market Drivers
8.3 Drug Eluting Peripheral Stents Market Challenges
8.4 Drug Eluting Peripheral Stents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Drug Eluting Peripheral Stents Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Drug Eluting Peripheral Stents Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Drug Eluting Peripheral Stents Market Competitive Situation by Manufacturers in 2022
Table 4. Global Drug Eluting Peripheral Stents Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Drug Eluting Peripheral Stents Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Drug Eluting Peripheral Stents Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Drug Eluting Peripheral Stents Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Drug Eluting Peripheral Stents, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Drug Eluting Peripheral Stents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Peripheral Stents, Product Type & Application
Table 12. Global Key Manufacturers of Drug Eluting Peripheral Stents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Peripheral Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Peripheral Stents as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Peripheral Stents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Drug Eluting Peripheral Stents Sales by Region (2018-2023) & (K Units)
Table 18. Global Drug Eluting Peripheral Stents Sales Market Share by Region (2018-2023)
Table 19. Global Drug Eluting Peripheral Stents Sales by Region (2024-2029) & (K Units)
Table 20. Global Drug Eluting Peripheral Stents Sales Market Share by Region (2024-2029)
Table 21. Global Drug Eluting Peripheral Stents Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Drug Eluting Peripheral Stents Revenue Market Share by Region (2018-2023)
Table 23. Global Drug Eluting Peripheral Stents Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Drug Eluting Peripheral Stents Revenue Market Share by Region (2024-2029)
Table 25. North America Drug Eluting Peripheral Stents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 27. North America Drug Eluting Peripheral Stents Sales by Country (2024-2029) & (K Units)
Table 28. North America Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Drug Eluting Peripheral Stents Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Drug Eluting Peripheral Stents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 32. Europe Drug Eluting Peripheral Stents Sales by Country (2024-2029) & (K Units)
Table 33. Europe Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Drug Eluting Peripheral Stents Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Drug Eluting Peripheral Stents Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Drug Eluting Peripheral Stents Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Drug Eluting Peripheral Stents Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Drug Eluting Peripheral Stents Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Drug Eluting Peripheral Stents Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Drug Eluting Peripheral Stents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Drug Eluting Peripheral Stents Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Drug Eluting Peripheral Stents Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Drug Eluting Peripheral Stents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Drug Eluting Peripheral Stents Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Drug Eluting Peripheral Stents Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Drug Eluting Peripheral Stents Sales (K Units) by Type (2018-2023)
Table 51. Global Drug Eluting Peripheral Stents Sales (K Units) by Type (2024-2029)
Table 52. Global Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Table 53. Global Drug Eluting Peripheral Stents Sales Market Share by Type (2024-2029)
Table 54. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2018-2023)
Table 57. Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2024-2029)
Table 58. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Type (2018-2023)
Table 59. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Type (2024-2029)
Table 60. Global Drug Eluting Peripheral Stents Sales (K Units) by Application (2018-2023)
Table 61. Global Drug Eluting Peripheral Stents Sales (K Units) by Application (2024-2029)
Table 62. Global Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Table 63. Global Drug Eluting Peripheral Stents Sales Market Share by Application (2024-2029)
Table 64. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Drug Eluting Peripheral Stents Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2018-2023)
Table 67. Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2024-2029)
Table 68. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Application (2018-2023)
Table 69. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Application (2024-2029)
Table 70. Boston Scientific Corporation Corporation Information
Table 71. Boston Scientific Corporation Description and Business Overview
Table 72. Boston Scientific Corporation Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Boston Scientific Corporation Drug Eluting Peripheral Stents Product
Table 74. Boston Scientific Corporation Recent Developments/Updates
Table 75. W. L. Gore & Associates Corporation Information
Table 76. W. L. Gore & Associates Description and Business Overview
Table 77. W. L. Gore & Associates Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. W. L. Gore & Associates Drug Eluting Peripheral Stents Product
Table 79. W. L. Gore & Associates Recent Developments/Updates
Table 80. Abbott Laboratories Corporation Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Laboratories Drug Eluting Peripheral Stents Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. iVascular SLU. Corporation Information
Table 86. iVascular SLU. Description and Business Overview
Table 87. iVascular SLU. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. iVascular SLU. Drug Eluting Peripheral Stents Product
Table 89. iVascular SLU. Recent Developments/Updates
Table 90. Meril Life Sciences Pvt. Ltd. Corporation Information
Table 91. Meril Life Sciences Pvt. Ltd. Description and Business Overview
Table 92. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product
Table 94. Meril Life Sciences Pvt. Ltd. Recent Developments/Updates
Table 95. Stentys SA, Cook Medical Inc. Corporation Information
Table 96. Stentys SA, Cook Medical Inc. Description and Business Overview
Table 97. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product
Table 99. Stentys SA, Cook Medical Inc. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Drug Eluting Peripheral Stents Distributors List
Table 103. Drug Eluting Peripheral Stents Customers List
Table 104. Drug Eluting Peripheral Stents Market Trends
Table 105. Drug Eluting Peripheral Stents Market Drivers
Table 106. Drug Eluting Peripheral Stents Market Challenges
Table 107. Drug Eluting Peripheral Stents Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Eluting Peripheral Stents
Figure 2. Global Drug Eluting Peripheral Stents Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Drug Eluting Peripheral Stents Market Share by Type in 2022 & 2029
Figure 4. Carotid Artery Product Picture
Figure 5. Iliac Artery Product Picture
Figure 6. Infrapop Artery Product Picture
Figure 7. Renal Artery Product Picture
Figure 8. Carotid Artery Product Picture
Figure 9. Global Drug Eluting Peripheral Stents Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Drug Eluting Peripheral Stents Market Share by Application in 2022 & 2029
Figure 11. Hospitals
Figure 12. Specialty Clinics
Figure 13. Ambulatory Surgical Centers/Outpatients
Figure 14. Global Drug Eluting Peripheral Stents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Drug Eluting Peripheral Stents Market Size (2018-2029) & (US$ Million)
Figure 16. Global Drug Eluting Peripheral Stents Sales (2018-2029) & (K Units)
Figure 17. Global Drug Eluting Peripheral Stents Average Price (US$/Unit) & (2018-2029)
Figure 18. Drug Eluting Peripheral Stents Report Years Considered
Figure 19. Drug Eluting Peripheral Stents Sales Share by Manufacturers in 2022
Figure 20. Global Drug Eluting Peripheral Stents Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Drug Eluting Peripheral Stents Players: Market Share by Revenue in 2022
Figure 22. Drug Eluting Peripheral Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Drug Eluting Peripheral Stents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2029)
Figure 25. North America Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2029)
Figure 26. United States Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2029)
Figure 29. Europe Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2029)
Figure 30. Germany Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Drug Eluting Peripheral Stents Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Drug Eluting Peripheral Stents Revenue Market Share by Region (2018-2029)
Figure 37. China Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2029)
Figure 47. Latin America Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Drug Eluting Peripheral Stents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Drug Eluting Peripheral Stents by Type (2018-2029)
Figure 57. Global Revenue Market Share of Drug Eluting Peripheral Stents by Type (2018-2029)
Figure 58. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Drug Eluting Peripheral Stents by Application (2018-2029)
Figure 60. Global Revenue Market Share of Drug Eluting Peripheral Stents by Application (2018-2029)
Figure 61. Global Drug Eluting Peripheral Stents Price (US$/Unit) by Application (2018-2029)
Figure 62. Drug Eluting Peripheral Stents Value Chain
Figure 63. Drug Eluting Peripheral Stents Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 薬剤溶出ステント噴霧機のグローバル市場展望 2023年-2029年：卓上型、床置き型
  • PTA薬剤溶出バルーンのグローバル市場展望 2023年-2029年：パクリタキセルコーティング、その他
  • 冠動脈疾患用薬剤溶出バルーンのグローバル市場展望 2023年-2029年：パクリタキセルコーティング、その他コーティング
  • 薬剤溶出バルーンカテーテルのグローバル市場展望 2023年-2029年：ポリウレタン、ナイロン、その他
  • 末梢血管疾患用薬剤コーティングバルーンのグローバル市場展望 2023年-2029年：パクリタキセルコーティング、その他コーティング
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7825 )"薬剤溶出性ステントの世界市場2023年：頸動脈、腸骨動脈、股間節動脈、腎動脈、頸動脈" (英文：Global Drug Eluting Peripheral Stents Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。